Leukoaraiosis can be treated with medications such as thalidomide, and it is recommended that the medication be used under a doctor’s supervision.
Leukoaraiosis, also known as Behçet’s disease, is a chronic systemic vascular inflammatory disease, which is characterized by recurrent oral and vulvar ulcers, ophthalmia and skin damage. Treatment in rheumatology is recommended.
The treatment of leukoaraiosis should follow the principle of individualization, and it can be treated with immunomodulatory drug thalidomide, non-steroidal anti-inflammatory drugs such as ibuprofen, as well as glucocorticosteroids such as prednisone and immunosuppressive drugs such as azathioprine.
Thalidomide has immunosuppressive, immunomodulatory, and anti-inflammatory effects, and can be used to treat leprosy and oncotic leprosy flare-ups. Adverse reactions such as dry mouth, nausea, vomiting, nausea, drowsiness and rash may occur during use. Allergic to the drug, children, pregnant and lactating women, drivers are prohibited. Take care that the drug is kept out of the reach of children.
Thalidomide should be used under medical supervision and in case of discomfort.